Published in J Am Soc Nephrol on October 01, 2002
The acid-ash hypothesis revisited: a reassessment of the impact of dietary acidity on bone. J Bone Miner Metab (2014) 0.77
Osteocalcin, but not deoxypyridinoline, increases in response to isoflurane-induced anaesthesia in young female guinea pigs. J Bone Miner Metab (2014) 0.75
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol (2007) 2.73
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J (2011) 2.14
Differences between dialysis modality selection and initiation. Am J Kidney Dis (2012) 1.81
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant (2008) 1.81
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int (2005) 1.74
Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2014) 1.41
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol (2003) 1.35
Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther (2006) 1.33
Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol (2003) 1.33
Bone buffering of acid and base in humans. Am J Physiol Renal Physiol (2003) 1.23
Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol (2009) 1.21
Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens (2004) 1.11
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res (2004) 1.00
Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant (2007) 0.99
Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol (2005) 0.99
Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int (2004) 0.97
Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens (2006) 0.97
Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1. J Bone Miner Res (2009) 0.97
Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol (2003) 0.95
Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism. J Bone Miner Res (2003) 0.95
Sensitivity and specificity of 24-hour urine chemistry levels for detecting elevated calcium oxalate and calcium phosphate supersaturation. Can Urol Assoc J (2008) 0.95
Uric acid nephrolithiasis. Curr Rheumatol Rep (2007) 0.95
Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol (2012) 0.92
Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus). Genetics (2012) 0.91
Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail. J Bone Miner Res (2010) 0.90
Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro. J Bone Miner Res (2007) 0.90
Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol (2006) 0.88
Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis (2011) 0.88
Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength. J Bone Miner Res (2009) 0.86
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol (2013) 0.86
Calcium and phosphorus homeostasis. Blood Purif (2009) 0.86
Idiopathic hypercalciuria. Curr Rheumatol Rep (2006) 0.86
When is it appropriate to order an ionized calcium? J Am Soc Nephrol (2008) 0.86
Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification. PLoS One (2013) 0.85
RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. Am J Physiol Renal Physiol (2005) 0.83
Cellular mechanisms of bone resorption induced by metabolic acidosis. Semin Dial (2003) 0.82
1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2013) 0.81
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. Hemodial Int (2012) 0.80
Pharmacological inhibition of intracellular calcium release blocks acid-induced bone resorption. Am J Physiol Renal Physiol (2010) 0.80
Recurrent hypercalciuric nephrolithiasis--does diet help? N Engl J Med (2002) 0.78
Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat. Curr Opin Nephrol Hypertens (2015) 0.78
Diuretics and disorders of calcium homeostasis. Semin Nephrol (2011) 0.78
Effect of metabolic and respiratory acidosis on intracellular calcium in osteoblasts. Am J Physiol Renal Physiol (2010) 0.77
Making sense of the latest advice on vitamin D therapy. J Am Soc Nephrol (2011) 0.77
Clinical application of calcium modeling in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 0.77
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats. Calcif Tissue Int (2014) 0.76
The relation between bone and stone formation. Calcif Tissue Int (2012) 0.75
Something old, something new, something borrowed, something black. Curr Opin Nephrol Hypertens (2017) 0.75
An in silico method to predict net calcium transfer during hemodialysis. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Nutritional vitamin D: the benefits of supplementation. Curr Opin Nephrol Hypertens (2008) 0.75
Innovations in bones and stones. Curr Opin Nephrol Hypertens (2013) 0.75
The beehive and the merry-go-round in mineral metabolism. Curr Opin Nephrol Hypertens (2011) 0.75
Bone disease in chronic kidney disease: unraveling the details. Curr Opin Nephrol Hypertens (2009) 0.75
Mineral metabolism: confusion to clarity. Curr Opin Nephrol Hypertens (2012) 0.75
Bones and stones, edition 2015. Curr Opin Nephrol Hypertens (2015) 0.75
Keeping divalent ions in their proper place. Curr Opin Nephrol Hypertens (2010) 0.75
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes. Am J Nephrol (2017) 0.75